Skip to main content
Premium Trial:

Request an Annual Quote

CHOP, In Brief Defense, Says Decode Suit 'Without Merit'

NEW YORK (GenomeWeb News) – The Children’s Hospital of Philadelphia said today that Decode Genetics' lawsuit against it and four officials is “without merit.”
 
The hospital also said it “defends physicians to protect advanced research in childhood diseases.”
 
“It would be a blow to the enormous promise of [the hospital's] research if a for-profit company is permitted to interfere with the potential advancement of healthcare for children,” CHOP President and CEO Steven Altschuler said in a statement.
 
In its lawsuit, Decode accuses the hospital and certain CHOP staffers who were formerly employed by Decode of sharing company trade secrets and intellectual property. One of the defendants is Hakon Hakonarson, director of the hospital’s Center for Applied Genomics.
 
The children’s hospital launched the business unit in June to identify genes responsible for common childhood diseases, such as asthma, obesity, and diabetes.
The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.